| CAS登錄號(hào) | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 123994-85-4 | 6H-Purin-6-one,2-[[(4-chlorophenyl)methyl]amino]-1,9-dihydro-; 6H-Purin-6-one,2-[[(4-chlorophenyl)methyl]amino]-1,7-dihydro- (9CI); NSC 682523 |  | C12H10ClN5O | 詳情 | 供應(yīng)商 | |
| 100890-94-6 | 6H-Purin-6-one,2,8-diamino-1,9-dihydro-9-(phenylmethyl)-; 8-Amino-9-benzylguanine; NSC 650999 |  | C12H12N6O | 詳情 | 供應(yīng)商 | |
| 26108-40-7 | 6H-Dibenzo[b,d]pyran-9-methanol,6a,7,8,10a-tetrahydro-1-hydroxy-6,6-dimethyl-3-pentyl- |  | C21H30O3 | 詳情 | 供應(yīng)商 | |
| 122113-10-4 | 6H-Pyrrolo[2,3-d]pyrimidin-6-one,5,7-dihydro-7-methyl-2-[(1-methylethyl)amino]-, hydrochloride (1:1); 6H-Pyrrolo[2,3-d]pyrimidin-6-one,5,7-dihydro-7-methyl-2-[(1-methylethyl)amino]-, monohydrochloride (9CI) |  | C10H15ClN4O | 詳情 | 供應(yīng)商 | |
| 147436-25-7 | 6H-Pyrrolo[4,3,2-ef][2]benzazepin-6-one,3-(aminomethyl)-1,3,4,5-tetrahydro-; 6H-Azepino[5,4,3-cd]indol-6-one,3-(aminomethyl)-1,3,4,5-tetrahydro- (9CI); 6H-Azepino[5,4,3-cd]indol-6-one,3-(aminomethyl)-1,3,4,5-tetrahydro-, (?à)-; KC-9048 |  | C12H13N3O | 詳情 | 供應(yīng)商 | |
| 109321-99-5 | 6H-Indolo[2,3-b]quinoxaline-6-aceticacid, 2-chloro-, 2-(phenylmethylene)hydrazide; 6H-Indolo[2,3-b]quinoxaline-6-aceticacid, 2-chloro-, (phenylmethylene)hydrazide (9CI) |  | C23H16ClN5O | 詳情 | 供應(yīng)商 | |
| 70661-73-3 | 6H-Purine-6-thione,1,9-dihydro-9-[3-hydroxy-1-(hydroxymethyl)propyl]-, hydrochloride (1:1); 6H-Purine-6-thione,1,9-dihydro-9-[3-hydroxy-1-(hydroxymethyl)propyl]-, monohydrochloride (9CI) |  | C9H13ClN4O2S | 詳情 | 供應(yīng)商 | |
| 16720-05-1 | 6H-Dibenzo[b,d]pyran-3-ol,2-hexyl-7,8,9,10-tetrahydro-6,6-dimethyl-; 3-Hydroxy-2-hexyl-6,6-dimethyl-7,8,9,10-tetrahydro-6-dibenzopyran |  | C21H30O2 | 詳情 | 供應(yīng)商 | |
| 87453-63-2 | 6,14-Ethenomorphinan-3-ol,7-amino-4,5-epoxy-6-methoxy-17-methyl-, (5a,7a)- (9CI); 7a-Amino-6,14-endo-ethenotetrahydrooripavine; MCV 4438; NIH 10093 |  | C20H25N2O3 | 詳情 | 供應(yīng)商 | |
| 70681-20-8 | 6,7-Isoquinolinediol,1,2,3,4-tetrahydro-1-methyl-, hydrochloride (1:1); 6,7-Isoquinolinediol,1,2,3,4-tetrahydro-1-methyl-, hydrochloride (9CI); (?à)-Salsolinol hydrochloride |  | C10H14ClNO2 | 詳情 | 供應(yīng)商 | |
| 146609-08-7 | 6H-Purin-6-one,2-amino-1,9-dihydro-9-[tetrahydro-4-(hydroxymethyl)-2-furanyl]-, (2S-cis)-(9CI) |  | C10H13N5O3 | 詳情 | 供應(yīng)商 | |
| 3389-27-3 | 6H-Indolo[2,3-a]quinolizin-5-ium,7,12-dihydro-, chloride (8CI,9CI); 6,7-Dihydro-12H-indolo[2,3-a]quinoliziniumchloride (6CI); 7,12-Dihydro-6H-indolo[2,3-a]quinolizin-5-ium chloride (7CI) |  | C15H13ClN2 | 詳情 | 供應(yīng)商 | |
| 30810-97-0 | 6,9-Methanonaphtho[1,2-c]furan-1,3-dione; 1,4-Methanonaphthalene-5,6-dicarboxylicanhydride (8CI) |  | C13H6O3 | 詳情 | 供應(yīng)商 | |
| 13196-11-7 | 6-Benzofuranol; 6-Hydroxybenzo[b]furan; 6-Hydroxybenzofuran |  | C8H6O2 | 詳情 | 供應(yīng)商 | |
| 30115-72-1 | 6H-Dibenz[c,g]azonine-6-ethanamine,N,N-diethyl-5,7,12,13-tetrahydro-, hydrochloride (1:1); 5H-Dibenz[c,g]azonine,6-[2-(diethylamino)ethyl]-6,7,12,13-tetrahydro-, monohydrochloride (8CI) |  | C22H31ClN2 | 詳情 | 供應(yīng)商 | |
| 53460-46-1 | 6-Azabicyclo[3.2.1]octane,1,3,3-trimethyl-; 1,3,3-Trimethyl-6-azabicyclo[3.2.1]octane |  | C10H19N | 詳情 | 供應(yīng)商 | |
| 64546-10-7 | 6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-2-methanol,4-(2-chlorophenyl)-a,9-dimethyl-; 6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-2-methanol,(2-chlorophenyl)-a,9-dimethyl-(9CI) |  | C17H15ClN4OS | 詳情 | 供應(yīng)商 | |
| 832-68-8 | 6-Phenanthridinamine; Phenanthridine,6-amino- (6CI,7CI,8CI); 6-Aminophenanthridine |  | C13H10N2 | 詳情 | 供應(yīng)商 | |
| 55750-00-0 | 6-14-Bombesin; Ranatensin,1-de(5-oxo-L-proline)-2-de-L-valine-3-L-asparagine-10-L-leucine-; 8: PN:US20100015058 SEQID: 7 claimed protein; Bombesin C-terminal nonapeptide; Bombesin(6-14); Bombesin-9 |  | C47H71N15O11S | 詳情 | 供應(yīng)商 | |
| 117-51-1 | 6H-Dibenzo[b,d]pyran-1-ol,3-hexyl-7,8,9,10-tetrahydro-6,6,9-trimethyl-; 6-Dibenzopyran-1-ol,3-hexyl-7,8,9,10-tetrahydro-6,6,9-trimethyl- (4CI); 3-Homotetrahydrocannibinol; Pyrahexyl; Synhexyl |  | C22H32O2 | 詳情 | 供應(yīng)商 | |